Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM in cell-free assays, respectively. Dasatinib induces autophagy and apoptosis with anti-tumor activity.
声明:
如果该化合物涉及专利保护,请勿作为商业目的使用,且仅供实验分析及研究之目的;如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。